Slow infection due to lowering amount of intact versus empty particles is a characteristic feature of Coxsackievirus B5, dictated by the structural proteins
Turkki, P., Laajala, M., Stark, M., Vandesande, H., Sallinen-Dal Maso, H., Shroff, S., Sävneby, A., Galitska, G., Lindberg, A. M., & Marjomäki, V. (2019). Slow infection due to lowering amount of intact versus empty particles is a characteristic feature of Coxsackievirus B5, dictated by the structural proteins. Journal of Virology, 93(20), e01130-19. https://doi.org/10.1128/JVI.01130-19
Published inJournal of Virology
© 2019 American Society for Microbiology
Enterovirus B species typically cause a rapid cytolytic infection leading to efficient release of progeny viruses. However, they are also capable of persistent infections in tissues, which are suggested to contribute to severe chronic states such as myocardial inflammation and type 1 diabetes. In order to understand the factors contributing to differential infection strategies, we constructed a chimera by combining the capsid proteins from a fast cytolysis causing echovirus 1 (EV1) with non-structural proteins from Coxsackievirus B5 (CVB5) showing persistent infection in RD cells. The results showed that the chimera behaved similar to the parental EV1 leading to efficient cytolysis in both permissive A549 and semi-permissive RD cells. In contrast to EV1 and chimera, CVB5 replicated slower in permissive cells and showed persistent infection in semi-permissive cells. However, there was no difference in the efficiency of uptake of CVB5 in A549 or RD cells in comparison to the chimera or EV1. CVB5 virus batches constantly contained significant amounts of empty capsids, also in comparison to its close relative CVB3. During successive passaging of batch containing only intact CVB5, increasing amounts of empty and decreasing amounts of infective capsids were produced. Our results demonstrate that the increased amounts of empty particles and lowering amounts of infective particles is dictated by the CVB5 structural proteins leading to slowing down the infection between passages. Furthermore, the key factor for persistent infection is the low amount of infective particles produced, not the high number of empty particles accumulating. ...
PublisherAmerican Society for Microbiology
Publication in research information system
MetadataShow full item record
Related funder(s)Jane and Aatos Erkko Foundation
Additional information about fundingThis work was supported by the Jane and Aatos Erkko Foundation (V.M.).
Showing items with similar title or keywords.
Martikainen, Mari (University of Jyväskylä, 2016)Enterovirus B group (EV-B) viruses are important human pathogens which cause a variety of diseases from mild respiratory illnesses to more severe acute infections such as myocarditis and meningitis. EV-Bs have also ...
Laajala, Mira; Hankaniemi, Minna M.; Määttä, Juha A. E.; Hytönen, Vesa P.; Laitinen, Olli H.; Marjomäki, Varpu (MDPI, 2019)Enteroviruses are small RNA viruses that cause diseases with various symptoms ranging from mild to severe. Enterovirus proteins are translated as a single polyprotein, which is cleaved by viral proteases to release capsid ...
Matilainen, Johanna (2016)Aggresomin muodostuminen on yksi solun puolustusmekanismeista, joka pyrkii estämään proteiinien haitallisen aggregoitumisen solulimassa. Aikaisemmat kokeet ovat näyttäneet, että ihmisen enterovirus-infektio aiheuttaa ...
Galibert, Lionel; Hyvönen, Amira; Eriksson, Reetta A. E.; Mattola, Salla; Aho, Vesa; Salminen, Sami; Albers, Justin D.; Peltola, Sanna K.; Weman, Saija; Nieminen, Tiina; Ylä-Herttuala, Seppo; Lesch, Hanna P.; Vihinen-Ranta, Maija; Airenne, Kari J. (Nature Publishing Group, 2021)With a limited coding capacity of 4.7 kb, adeno-associated virus (AAV) genome has evolved overlapping genes to maximise the usage of its genome. An example is the recently found ORF in the cap gene, encoding membrane-associated ...
Myllymäki, Laura (2023)Enterovirukset ovat yleisiä RNA-viruksia, jotka aiheuttavat monenlaisia sairauksia ihmisille. Huolimatta pyrkimyksistä kehittää tehokkaita ja laajakirjoisia antiviraaleja, tällä hetkellä enterovirusinfektioiden hoitamiseksi ...